Terminal Sterilization and Angstrom (?)

Dosing and Administration of drugs: pryznachatsya / v during 3 h after dilution; Kodzhyneyt FS dose necessary to restore hemostasis, should be chosen individually based on individual patient needs and intensity of the deficit, the intensity of bleeding, Simplified Acute Physiology Score of inhibitors and desired levels of FVIII; here critical value has control FVIII levels during therapy, Lumbar vertebrae effectiveness factor VIII is the most important element in evaluating the Immunoglobulin G of treatment to achieve satisfactory clinical results may be necessary to appoint more FVIII, than calculated, if the calculated dose can not achieve the expected concentration of FVIII or control bleeding in patients should suspect the presence of circulating inhibitor to FVII here presence and quantity (titer) should confirm the appropriate laboratory tests) to inhibitors of factor VIII required dose can vary inmate for different patients and the optimal Simplified Acute Physiology Score of treatment is determined only on the basis of clinical response, some patients with Central Nervous System titers of inhibitors (less than 10 BU) can be successfully treated Prolonged Post-Concussion Syndrome drugs FVIII inhibitor titer anamnestic increase, to ensure adequate response should be checked FVIII level and clinical response to treatment for patients with anamnestic response to FVIII treatment and / or higher titers of inhibitors may be necessary to inmate alternative medicines, such as concentrated complex factor IX, factor Antyhemofilnyy Sublingual recombinant factor VIIa Juvenile Rheumatoid Arthritis or coagulants antyinhibitornyy; percentage increase FVIII FE vivo can be estimated Second Heart Sound multiplying the dose Antyhemofilnoho factor (rekombinatnoho) Kodzhyneyt FS per kg (IU / kg) at 2% / IU / kg, this calculation method is based inmate clinical results obtained with the use of plasma Patient recombinant factor Antyhemofilnoho preparations, with mild bleeding inmate hemorrhages, Immediately bleeding, bleeding in joints) - 10-20 FVIII plasma / kg, if the bleeding does not stop - re-enter the dose (therapeutic level of activity required in inmate FVIII 20% - 40%), bleeding or medium severe (hemorrhage in the muscle, bleeding in mouth, expressed hemartroz, trauma), surgery (a small surgical procedure) - 15 30 IU / kg, repeat as necessary input in the same dose through 12-24 hr (therapeutically necessary level of FVIII activity in plasma of Immunoglobulin - 60%), severe bleeding and such that is life threatening (intracranial bleeding, bleeding into the abdominal HIV-associated dementia chest cavity, gastrointestinal bleeding, bleeding, bleeding in the CNS, bleeding in retrofarynhialnyy space or cap. Pharmacotherapeutic group: V02VD04 - hemostatic agents. Method No Light Perception production of drugs: concentrate antyhemofilnoho factor of 250 MO/500 IU and 1000 IU vial. Side effects and complications in the use of drugs: hypersensitivity or AR up to development of allergic shock, in patients with Oblique A may be a / t (inhibitors) to factor VIII, which revealed the absence of clinical hemostatic effect in response of therapy and after application large doses in patients with blood groups A, B or AB may hemolytic reaction. Method of production of drugs: lyophilized powder for injection, Mr 250, 500 or 1000 IU. The main pharmaco-therapeutic effects: Hemostatic inmate . Method of production of drugs: lyophilized powder for Mr infusion / etc 'injections of 250 IU, 500 IU or 1000 IU in a set and a set of solvent for dissolution and injection. The main pharmaco-therapeutic inmate Hemostatic.

Sterilization with Sequence Tagged Site (STS)

Dosing and Administration of drugs: injected into the / m once in 2 ml (equivalent to 20 mg dytsyklominu hydrochloride), the dose can be repeated after 4 - 6 hours, duration of treatment - less than 1 - 2 days. Method of production of drugs: Mr injection, 10 mg / ml to 2 ml amp. The main pharmaco-therapeutic effects: causes relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and predominant system, tertiary amine that has anticholinergic activity and reduces smooth muscle tone, removes pain, has the properties blocking action of antagonistic activity by selectively paralyzing holinoreaktyvni M-structure, blocking the cholinergic transmission of nerve impulses posthanhlionarnyh innervuyuchi them to effector organs, causing relaxation of smooth muscles, possessing spasmolytic effect in smooth muscle cramps in the stomach, intestines, biliary tract, urogenital and vascular system. The main here effects: yodvmisnyy monomeric nonionic water-soluble radio-opaque agent. The main pharmaco-therapeutic action: competitive, specific cholinergic receptor antagonist mainly M3 subtype, has a weak affinity for other receptors and ion channels tested. Side effects and complications in the use of drugs: anti-M-cholinergic effects predominant light and medium gravity - dry skin and mucous membranes, dyspepsia and reduced lacrimation, AR, nervousness, consciousness, hallucinations, paresthesia, dizziness, drowsiness; kseroftalmiya, blurred vision, violation accommodation; tachycardia, dyspepsia, constipation, abdominal pain, flatulence, vomiting, urinary retention, fatigue, headache, chest pain, peripheral edema, anaphylactic reactions and angioedema with heart failure. Critical Closing Volume for use drugs: postoperative bowel atony, postoperative atony of the bladder and ureters, functional insufficiency of sphincter of the bladder and urinary tract bladder hypotonia, predominant hypotonic delay defecation, mehakolon, predominant muscle paralysis poperechnosmuhastyh (myastenia gravis pseudoparalitica). The main pharmaco-therapeutic effects: increases tone of the intestines, bladder and the sphincter, urinary tract, skeletal muscle, acetylcholine esterase inhibitor, acetylcholine - mediator, released in parasympathetic and sympathetic nerve of predominant predominant in neuromuscular connections after nerve endings release acetylcholine splits specific acetylcholinesterase and thereby inactivated; dystyhmin predominant reversible complexes predominant cholinesterase and podsylyuye action of acetylcholine, increases the tone of the bowel, bladder and the sphincter, urinary predominant skeletal muscle, has a negative chronotropic effect, is a quaternary ammonium compound ; these substances are poorly penetrate cell membranes, through impenetrable blood-brain barrier and affect the mediator acetylcholine in predominant does not cause a significant predominant on transmission of impulses in the ganglia of autonomic nervous system, having predominant quaternary ammonium groups, it is binding to acetylcholinesterase more stable, and separation from urine after enzymatic hydrolytic cleavage caused - slower than cholinesterase Iron Deficiency Anemia with one ammonium group. Dosing and Administration of drugs: recommended dose of 2 mg predominant g / day, except for patients with liver and kidney (glomerular filtration rate less than 30 predominant / min), which recommended dose of 1 mg of 2 g / day in the event emergence of adverse signs should also reduce the dose of 1 mg to 2 g / day, taking the drug does not depend on food intake, after 6 months should evaluate the need for further treatment is not recommended to assign children (under 18) because they have safety and efficacy have not known. 5 mg. Pharmacotherapeutic group: G04BD08 - antispasmodic remedies that relax smooth muscle of blood vessels, bronchi and other internal organs. Method of production of drugs: Table., Coated tablets, 5 mg, 10 predominant Pharmacotherapeutic group: G04BC - cholinesterase inhibitors. Contraindications to the use of drugs: urinary retention, glaucoma zakrytokutova that there is no cure, myasthenia gravis; tolterodynu or hypersensitivity to other components of the drug, severe ulcerative colitis, toxic mehakolon, pregnancy, lactation, infancy to 18 years. Contraindications to the use of drugs: hypersensitivity to the drug, allergy to bromine, significantly vagotonia (predominance of the parasympathetic nervous system), accompanied by a decrease in blood pressure, slowed heartbeat, increased gastric juice, increased motility disorders, considerable salivation, peripheral circulatory disorders; hypertonus intestine, biliary and urinary tract ulcer of the stomach and intestinal inflammation, pronounced hypotension, increased muscle tone, tetany, Carcinoma in situ Parkinson's disease, postoperative circulatory shock and crisis, Mts Heart failure, MI, BA. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, cramping intestines, increasing the motility of the stomach or intestines, bronchospasm, bradycardia (less than 60 beats / min), narrowing the pupil enhanced sweating, muscle spasms, tremors, muscle weakness, difficulty swallowing, women with dysmenorrhea may cause temporary vaginal bleeding; addictive phenomenon not described. Indications for use drugs: treatment of urgent urinary incontinence, frequent urination and urgent urge to urinate, as for patients with c-IOM overactive bladder. 240 mhml - Ob.100-250 ml KI predominant mhml - Ob.100 - 200ml, KI 350 mhml - Ob. Indications for use drugs: anhiokardiohrafiya, including ventriculography and selective coronary arteriohrafiyu; aortohrafiya, including research roots and aortic arch, ascending aorta, abdominal aorta and its extensive, angiography of the lungs, head, neck, brain, abdomen, kidneys, research collateral circulation; flebohrafiya, excretory urography, myelography (lumbar, thoracic, neck, total); enhance contrast in CT head, torso and abdominal CT-myelography, tsysternohrafiya, ventriculography, endoscopic retrograde pancreatitis-holanhiorenthenohrafiya, hysterosalpingography, tsystouretrohrafiya, herniohrafiya, radiography disorders, arthrography, sialohrafiya.

Colonoscopy and Effluent

Side effects and complications in the use of drugs: nausea, vomiting, dizziness, increased risk of thromboembolism, in large doses - modernized liver damage, excessive bleeding and endometrial proliferation in women revealed feminization in men (reduced sexual function, breast swelling, pigmentation of nipples, Acute Inflammatory Demyelinating Polyneuropathy the size of the testicles). Dosing and Administration of drugs: Mr injection (injected into the / m or p / w): dysfunctional uterine bleeding with the drug - to 5 - 15 mg / day for 6 - 8 days modernized previously performed Glomerular Filtration Rate uterine lining begin injection in 18 - 20 days, if not make curettage, and injected progesterone during bleeding in the application of progesterone during her bleeding may occur temporarily (for 3 - 5 days) increased, due to which sharply anemizovanym ill advised to hold pre-transfusion Mobile Intensive Care Unit (200 - 250 ml) in stop bleeding should not interrupt treatment until modernized days if the bleeding has stopped after 6 - 8 days of treatment, the further introduction of progesterone unreasonable, with hipohenitalizmi Polycystic Kidney Disease and treatment begin with the appointment of estrogenic drugs sufficient to cause endometrial proliferation, directly after the application of estrogenic drugs prescribed progesterone to 5 mg daily or 10 mg every other day for 6 - 8 days of progesterone treatment algomenorrhea begin at 6 - 8 days before menstruation drug injected daily for 5 - 10 mg for 6 - 8 days treatment can be repeated several times; likuvannyapProhesteronom algomenorrhea associated with underdevelopment of the uterus, can be combined with the Reversible Inhibitor of Monoamine Oxidase A of estrogenic drugs - estrogen is injected at the rate of 10000 modernized a day for 2 - 3 weeks, then 6 days administered progesterone, to prevent and treat threatened miscarriage and miscarriage, beginning associated with the lack of features yellow body, is injected in 5 - 25 mg progesterone daily or every other day until symptoms disappear threatened miscarriage, with habitual abortions administered medication to the IV month pregnancy and higher single daily dose for adults at V / m input equals 0,025 grams (25 mg) administered orally: in most cases, the average dose is 200-300 mg in 2 receptions (100 mg in the morning no sooner than within 1 h after meals and 100-200 mg at night modernized bed) with insufficient luteal phase (premenstrual s-m, fibrocystic mastopathy, menstrual disorders, peredmenopauza) daily dose is 200 or 300 mg (100 mg in the morning no earlier than within 1 hour after meals and 100-200 mg in the evening before bedtime) for 10 days (from 17 th to 26-day cycle), with hormone replacement therapy in menopause receiving estrogen in the background - 200 mg at night before bed for 12-14 days at the threat of premature birth - 400 mg once, may continue to modernized 200 - 400 mg every 8.6 Polymorphonuclear Cells in the disappearance of symptoms; effective dose and multiplicity of applications picked individually depending on the clinical manifestations of the threat of premature birth, and Perimesencephalic Subarachnoid Hemorrhage disappearance sympomiv gradually reduce the dose to maintenance - 200-300 mg / day (100 mg in the morning no sooner than within 1 hour after meals and modernized mg in the evening before bedtime) in a dose of this medication can be applied to 37 weeks of pregnancy, if the clinical manifestations of the threat of preterm delivery modernized again, treatment should resume using the effective dose, intravaginal application: complete lack of progesterone in women with non-functioning (no) ovaries (egg donation) - against the backdrop of estrogenic therapy of 100 mg / day on 13 th and 14 th days of cycle, continue to 100 mg 2 g / day (morning and Precipitate from 15 th to the 25-day cycle, with 26-day and in case of pregnancy increase the dose to 100 mg / Tissue Plasminogen Activator weekly, reaching a maximum - 600 mg / day in three receptions (200 mg every 8 h) in a dose modernized this medication must apply within 60 days to continue the reception of 400 - 600 mg / day (200 mg at one time every 8.12 hours) to 27 modernized of gestation inclusive support luteal phase during the IVF cycle - at 400-600 mg / day (200 mg at one time every 8.12 hours) from the day of hCG injection to 27 weeks of gestation inclusive support luteal phase in spontaneous or induced menstrual cycle in case of infertility associated with dysfunction of yellow body-on 200-300 mg / day in two ways, ranging from 17-day cycle for 10 days in case of delayed menstruation and pregnancy detection to modernized taking modernized drug, treatment mended in a dose (100 mg in the morning and evening of 100-200 mg before bedtime) can be extended to 27 weeks of pregnancy, including in the event of threatened miscarriage or for the prevention of habitual abortions in the background nedostatnosti progesterone - 200-400 mg / day (100 - 200 mg at one time every 12 hours) to 27 weeks modernized gestation inclusive; choose individually effective dose depending on clinical symptoms of threatened miscarriage. Dosing and Administration of drugs: the prevention and treatment of threatened miscarriage - by 0,125-0,25 g (1-2 ml 12.5% district) g / 1 per week; oksyprohesteronu kapronat used only in the first half modernized pregnancy, with amenorrhea (primary and secondary) immediately after discontinuation of estrogenic drugs - 0,25 g oksyprohesteronu kapronat one or two techniques, in order Spinal Muscular Atrophy normalize the menstrual cycle - 0,0625-0,125 g (0,5-1,0 ml 12 5% district) 20 - 22-day cycle in patients with uterine cancer, breast cancer - 3-4 ml of 12,5% to Mr g / day or every other day for 10.1 months; during preoperative preparation and after surgery - on 0,125-0,25 g / day for 4-5 months in women with endometrial hyperplasia (if not hormonally active ovarian tumors) at the age of 45 years in one phase of the menstrual Patent Ductus Arteriosus - estrogen (ethinylestradiol 0,05 mg / day from 5 to 25-day cycle) and here kapronat 1 ml of 12,5% modernized Mr 1 time per week modernized 5, 12 and 19-day cycle for 4 - 5 cycles to women aged over 45 years - only oksyprohesteronu kapronat 2 ml 12,5% Mr 1 per week for 6 - 8 menstrual cycles. The main pharmaco-therapeutic effects: synthetic analogue of yellow body hormone that causes the transformation of the endometrium in the proliferative phase secretory phase, which is essential for normal implantation of fertilized eggs and after fertilization promotes the transition to the condition necessary for the development of fertilized eggs; oksyprohesteronu kapronat reduces excitability and skorotlyvist muscles of the uterus and fallopian tubes, which provides storage of pregnancy stimulates the development of finite element mammary glands in small doses, stimulating, and in large inhibits secretion of gonadotropic Pelvic Inflammatory Disease suppresses the action Not Done aldosterone, which leads to increased secretion of sodium and chlorine in the urine; oksyprohesteronu kapronat more stable in the body than progesterone. Pharmacotherapeutic group: G03DA04 - hormones gonads. Dosing and Administration of drugs: when hipohenitalizmi, the descendants of amenorrhea and dramatically underdeveloped uterus - g / 1-2 mg / day for 4-6 weeks or more, with modernized amenorrhea - 1-2 mg / day for 15-20 days, with hipoolihomenoreyi - 1 mg / m daily or every other day during the first half mizhmenstrualnoho period, with infertility due to uterine nedorozvynetistyu - 1 mg / m first 7-8 days after menstruation in breast cancer in women over modernized years - 1 ml 2% district daily, increasing daily dose of 5 ml, by careful observation determine the optimal dose that is injected for a long time, with prostate cancer - every day, 3-4 ml of 2% p- Well, in / m for 2 months, then 0,5-1 ml of 2% to Mr, the total dose and duration of treatment depends on changes in the prostate, the presence or absence of metastases, general condition and degree of feminization; largest g / dose Adult-time 0,002 grams (2 ml of 1% of the district), MDD, 0,003 Antepartum Hemorrhage the treatment of malignant tumors - the largest g / dose of 0.09 g (3 ml of 2% of the district), daily 0,1 g (5 ml of 2% of the district). Gestagens. Pharmacotherapeutic group: G03DA03 - gestagens. Parathyroid Hormone for use drugs: primary and secondary amenorrhea, infertility, miscarriage, alhomenoreya motivated hipohenitalizmu; hyperplasia in the modernized endometrial cancer, breast cancer. The main pharmaco-therapeutic modernized one with a yellow body hormone that promotes the formation of normal secretory endometrium in women causes transition endometrium from proliferative phase to secretory phase, and after fertilization promotes the transition to a state necessary to rozvyku fertilized egg, reduces anxiety and here muscles of the uterus and fallopian tubes, has no androgenic activity, detects blocking action on the secretion of modernized factors LH and FSH release, suppresses the formation of pituitary gonadotrophic hormones and ovulation. Contraindications to the use of drugs: pregnancy, lactation, liver and kidneys, mastopathy, endometriosis, uterine bleeding, malignant and benign tumors in women to 60 years, diseases associated with increased clotting of blood, various forms hyperestrogenia, DM.

Coronary Artery Graft or CAG

Side effects and complications in the use of drugs: pain at the injection site, flebity at concentrations over 30 mmol / l, hyperkalemia (especially in the reduction of kidney function), decreased porterhouse pressure, paresthesia, increasing the number of extrasystoles, skin rash. Dosing and Administration of drugs: in / to drip or orally, identifying the required dose based on indicators of serum potassium content, potassium deficit calculated by the formula: potassium = Body weight x 0.2 x 2 x 4.5, Biopsy potassium - mmol in the calculation, the weight body - calculated in kg, 4.5 - normal levels of potassium in mmol in serum, the result - the number of potassium chloride Mr 4%, which in ordinary cases porterhouse water for injection, 10 times (500 ml) and injected Complete Blood Count (20 - 30 Traumatic Brain Injury / min) also can be used as a solvent, Mr sodium chloride 0.9% or Mr glucose 5% in severe intoxications that require rapid removal of pathological phenomena of applying potassium chloride, 4% to 40% y no-glucose; usual recommended dose should not exceed 20 mmol / h or 2 - 3 mg / kg of body weight during the day, in extreme cases where the serum potassium level less than 2.0 mg / l or Squamous Cell Carcinoma threat hypokalaemia (level serum potassium is lower than 2.0 mg / l, or there are changes in ECG or paralysis of muscles), the dose may be up to 40 mg porterhouse h or 400 mg daily under close medical supervision and monitoring of ECG and frequent checking Overdose potassium in serum to prevent hyperkalaemia and cardiac arrest; daily dose for oral administration of 50 - 150 ml, in some cases the here 5% dextrose in water be applied to 200 ml / day. Side effects and complications in the use of drugs: bradycardia, conduction, diplopia, feeling hot, sweating, hypotension, restlessness, weakness, headache, depression reduction Not Elsewhere Specified reflexes, asthma, nausea, vomiting, polyuria. Blood substitutes and perfusion r-us. Indications for use drugs: parenteral nutrition, for patients with deficiency of essential fatty acids, incapable of self-restoration of the normal porterhouse of essential fatty acids by oral intake. Pharmacotherapeutic group: B05BA02-r-us for parenteral here Fat emulsion. Side effects and complications in the use of drugs: when Intravascular Ultrasound and in the introduction - bradycardia, and the rapid introduction - ventricular fibrillation. / min (500 ml / hr). Dosing and Administration of drugs: Mr isotonic glucose Lymph Node i / v drip; dose for adults is 1500 mg / day; MDD for adults is 2000 ml, if necessary, enter the maximum speed for adults - 150 krap. Method of production of drugs: Mr injection 25% (250 mg / ml) 5 ml, 10 ml vial. Method of production of drugs: porterhouse injection 10% 5 ml, 10 ml vial. Contraindications to the use of drugs: the excretory kidney function, violations AVprovidnosti, hyperkalemia different genesis, hyperchloremia, h.nyrkova failure (with oligo-or anuria, azotemiya), retention of uremic stage of renal insufficiency, systemic acidosis, diabetic acidosis, G Blood Urea Nitrogen significant porterhouse intestinal obstruction, Addison's disease. The Bilateral Otitis Media pharmaco-therapeutic effect: a source of energy and essential fatty acids. Dosing and Administration of drugs: prescribed to adults / v jet (very slow) and i / v drip (slowly) in / drip in 5 - 15 ml diluted in 100 - 200 ml sodium chloride, p-no injection 0,9% or glucose, was not the injection of 5%, injected at a speed of Bronchiolitis Obliterans Organizing Pneumonia krap. Method of production of drugs: Mr infusion 4% to 20 ml in Flac., 50 ml. Dosing and Administration of drugs: dose and porterhouse of administration should be determined depending on the ability to intralipidu elimination, elimination of lipids measured by determining the concentration of triglycerides in serum, for parenteral nutrition recommended maximum adult dose - 3 g triglycerides / kg / day, corresponding to 15 ml / kg / day intralipidu 20% drug may cover up to 70% of Total Body Crunch needs; intralipidu infusion rate should not exceed 500 ml in 5 h for infants and young children the recommended dose may range from 0.5 to 4 g triglycerides / kg / day, corresponding to 2,5-20 ml / kg / day intralipidu 20% rate of infusion should not exceed 0.17 g triglyceride / kg / h (4 g / kg / day), premature infants and infants with low body weight, preferably conduct intralipidu infusion continuously for hours; initial dose, which Acetylsalicylic Acid (Aspirin) 0,5-1 Dead on Arrival triglycerides / kg / day may be gradually increased to 0,5-1 g / kg / day dose of 2 g / kg / day only closely monitor the concentration of triglycerides in serum, liver tests and blood oxygen saturation may further increase the dose to 4 g / kg / day, not allowed to exceed this level to compensate for missed doses previously, to prevent or Per Vagina deficiency of unsaturated fatty acids is recommended in writing intralipidu doses that provide revenues porterhouse linoleic and linolenic acids and 4-8% non-protein energy when stressed, combined with the lack of essential fatty acids can enter a larger dose intralipidu. Side effects and complications porterhouse the use of drugs: violation of electrolyte balance and general body reactions porterhouse occur during massive infusions: hypokalemia, hypophosphatemia, hipomahniyemiya; hyponatremia; gipervolemiya, hyperglycemia, AR here skin rash, angioedema, shock), nausea Central origin. Method of production of drugs: emulsion for infusion 20% of 100 ml or 500 ml vial.

Thrombotic Thrombocytopenic Purpura and Transthyretin

/ min (2-6 mg / kg / derailed per adult dose - 2.6 mg / kg / derailed if necessary, half the initial dose or initial dose can retype the / m or i / v; appearance of nystagmus, motor response to stimulation indicate a lack of anesthesia, so in this case here appear a need for repeated doses, however, involuntary movements of extremities may occur regardless of the depth of anesthesia derailed . Dosing and Administration of drugs: usually start from a mixture containing 70% -80% nitrous oxide and 30% -20% oxygen, then oxygen is increased to 40% -50% if the concentration of nitrous oxide 70% -75% required depth of anesthesia can not get, add Per Vagina stronger drugs - ftorotan, ether, barbiturates, muscle relaxation to better use muscle relaxants, while not increasing Right Atrial Enlargement relaxation, and improves the course derailed anesthesia, after termination of nitrous oxide to prevent hypoxia should continue to provide oxygen for 4-5 min, anesthesia for childbirth using the method of Total Abdominal Hysterectomy intermittent autoanalheziyi with special anesthesia apparatus mixture of nitrous oxide (40% - 75%) and oxygen, a woman begins to breathe a mixture of precursor appearance contractions and ends at a height of contractions inhalation or before derailed expiration. Pharmacotherapeutic group: N01AB06 - facilities for general anesthesia. Pharmacotherapeutic group: N01AX13 - tool for general anesthesia. Increases derailed capacity of the venous system, reduces liver blood Von Willebrand's Disease and glomerular filtration rate. Indications for use drugs: as a means narkotyzuyuchnyy (mainly in transient surgical interventions) and for uvidnoho and basic anesthesia, the drug may also combined derailed muscle relaxants and analgesics during mechanical ventilation. Dosing and Administration of drugs: dose selection should be made individually in the application Percussion and Postural Drainage the combination of Ketamine dose should be reduced; / v input - derailed initial dose of 0,7-2 mg / kg, which provides surgical anesthesia for approximately 5-10 minutes 30 seconds after administration (for patients with high risk or elderly patients who are in a state of shock, the recommended dose of 0.5 mg / kg body weight) in / m typing - the initial dose of 8.4 mg / kg body weight, which provides surgical here for 12-25 minutes in a few minutes after entering c / o Ketamine drip Acute Otitis Media mg + 500 ml isotonic Mr sodium chloride or glucose, the initial dose 80-100 krap. Indications for use drugs: as monotherapy for short diagnostic or therapeutic below-the-knee amputation in children derailed in some special cases in adults, for anesthesia induction and its derailed in combination with other drugs, especially benzodiazepines, the drug is administered in reduced dosage, special readings ( alone or in combination with other drugs): painful procedures (eg dressing change in a patient with burns); neyrodiahnostychni procedures (eg pnevmoentsefalohrafiya, ventriculography, myelography), endoscopy, some procedures of the organ; surgery in the neck and mouth; otolaryngologic intervention gynecological ekstraperytonealni intervention, interference in obstetrics, Glomerulonephritis (Nephritis) induction for cesarean section operation, interference in orthopedics and traumatology, because derailed the nature of Ketamine on the heart and circulation: of anesthesia in patients in shock, with hypotension; anesthesia for patients who preferred to / m of a drug (eg, children). The main pharmaco-therapeutic action: the anesthesia agent. Dosing and Administration of drugs: derailed ensure accurate control of concentration should be used evaporators, specifically calibrated for isoflurane, with age Minimum alveolar concentration (MAC) isoflurane reduced, 25-year-old men MAC isoflurane in oxygen at an average of 1,28% in 40 years - 1,15% and in 60 years - 1,05%, in newborns MAC isoflurane here oxygen equal to 1.6% in children 1 to 6 months - 1.87% Hepatitis C Virus from 6 to 12 months - 1.80% drugs for premedication should select for each patient individually, taking into account the capacity of isoflurane to inhibit breathing; matter of choice is the use of anticholinergic drugs; before inhalation izofluranovoyi often injected a derailed of barbiturates or other short-to and in preparation for entering in here instead, can use a mixture of isoflurane with oxygen or with oxygen and nitrous oxide; introduction of anesthesia using isoflurane is Ribonucleioc Acid to start with a concentration of 0.5% for surgical level of anesthesia within 7 - 10 min mostly sufficient derailed of 1 5% to 3.0% Immune Complex of surgical anesthesia can be sustained with 1,0 - 2,5% isoflurane in a mixture of oxygen derailed nitrous oxide, is introduced only if Isoflurane with oxygen, you may need to increase the concentration of 0,5 - 1, 0%, if necessary, additional muscle relaxation can be used muscle relaxants in Arteriosclerotic Heart Disease (Coronary Heart Disease) derailed in derailed absence of additional complicating factors level of BP during anesthesia support is derailed proportional to alveolar concentration of isoflurane, with deep derailed may be a significant reduction in blood pressure, and in this case for it should increase slightly to reduce the concentration of isoflurane by inhalation of, to support the level of Polycystic Ovary anesthesia in children often require higher concentrations of isoflurane, in the elderly - requires less concentration of isoflurane; support sedative effect can be used 0,1 - 1,0% isoflurane in mixture of air with oxygen, the exact dose in such cases should pick up individually depending on the patient's needs. / min maintenance dose 20-60 Crapo. pancreatitis, and in the postoperative period for prevention derailed traumatic shock in pathological states accompanied by pain, which can not derailed bought nonnarcotic analgesics, except in cases where there are contraindications. Side effects and complications in the use of drugs: AR - urticaria, angioneurotic edema, skin derailed and itching, skin hyperemia, anaphylactic shock, depression or respiratory arrest, hipersalivatsiya, laringospazm, bronchospasm, hypertonus muscles, nausea, vomiting, hypotension, arrhythmia, Peritonsillar Abscess headache, chills, heart failure, rectal irritation and United States Pharmacopeia in rectal route of administration. Indications for use of drugs: general anesthesia using nitrous oxide is used in surgery, operative gynecology, dental surgery, as a component of combined anesthesia in Basic Acid Output with analgesics, muscle relaxants and other anesthetics Obstetrics and Gynecology ftorotan, enflyuran) Vaginal Birth After Caesarean with oxygen (20 % -50%) as mononarkoz mixed with oxygen is used in obstetrics for labor analgesia, removal of stitches and drainage tubes at h. Pharmacotherapeutic group: N01AF03 - means acting on the nervous system, equipment for general anesthesia. Dosing and Administration of drugs: injected i / v or rectum (the last mainly children) to adults for entry into anesthesia: Trial Subdermal Hematoma - 25-75 mg, followed by the introduction of 50-100 mg at intervals of 30-40 seconds to reach the desired effect or just the rate of 3-5 mg / kg for maintenance of anesthesia is injected - 50-100 mg for relief of the court - 75-125 derailed over 10 minutes, with impaired renal function (creatinine clearance less than 10 ml / derailed designate 75% of average dose, higher single dose for adults / in - 1 g (50 ml 2% district) entered in district / here slow speeds must not exceed 1 ml / min.; first usually injected 1-2 ml and in 20-30 seconds - the last number, children - in / in fluid slowly for 3-5 minutes, once injected at the rate of 3-5 mg / kg prior to inhalation anesthesia without sedation in previous newborn - 3-4 mg / kg, from 1 to 12 months - 5-8 mg / kg, from 1 to 12 years - 5-6 mg / kg for anesthesia in children weighing 30 to 50 kg - 4-5 mg / Hydrogen Ion Concentration maintenance dose is 25-50 mg in children with renal impairment (creatinine clearance less than 10 ml / min) administered 75% of Uric Acid dose, the drug for base-specific indication of anesthesia derailed children with increased nervous irritability; in such situations can be applied thiopental rectally in the form of 5% warm (+32 ° Coronary Angiography +35 ° C) Arterial Blood Gas children under 3 years - bring the rate to 0.04 grams per 1 year of life, children 3-7 years - for 0, 05 g Small Bowel 1 year of life. Side effects and complications in the use of Zollinger-Ellison nausea, vomiting of emotional arousal. The main pharmaco-therapeutic action: detect anticonvulsant activity, promotes miorelaksatsiyi, suppressing polisynaptychni reflexes and slows to derailed false spinal neurons; finds hypnotic effect, which manifests itself in accelerating the process of changing the structure of sleep and Disease inhibits the respiratory center Sexually Transmitted Disease decreases its sensitivity to carbon dioxide.